I thought you would be interested to know that the Scottish Medicines Consortium have agreed to make Niraparib available as a maintenance treatment for women with relapsed ovarian cancer who do not have a BRCA mutation.
In England NICE have approved it under the Cancer Drugs Fund for women with relapsed high grade serous, platinum sensitive cancer. So if you thought this could apply to you, you would need to discuss it with your consultant who could then make an application to the Cancer Drugs Fund on your behalf.
Content on HealthUnlocked does not replace the relationship between you and doctors or other healthcare professionals nor the advice you receive from them.
Never delay seeking advice or dialling emergency services because of something that you have read on HealthUnlocked.